0,1,2,3,4,5,6,7
Table 2. aGVHD characteristics.,,,,,,,
Case,Prophylaxisa,GVHD onsetb,,GVHD stagec,,GVHD overall gradec,First-line treatment
,,,skin,liver,gut,,
1,CsA,113,1,0,3,III,P/CsA
2,CsA/MMF,27,0,1,3,III,P/CsA
3,-,357,0,0,4,III,P/CsA
4,CsA/MMF,84,0,0,3,III,P/CsA
5,CsA,50,0,2,3,III,P/CsA
6,CsA,23,3,0,3,III,P/CsA
7,CsA/MMF,61,3,0,4,III,P/CsA
8,CsA/MMF,27,0,1,4,III,P/CsA
9,CsA/MMF,126,0,0,4,III,P/CsA
10,CsA/MMF,39,0,0,3,III,P/CsA
11,MMF,393,0,1,4,III,P/CsA
12,CsA,79,0,0,2,III,P/MMF
13,CsA/MMF,41,3,0,2,III,P/CsA
14,MMF/P,86,0,1,3,III,P/CsA
15,CsA,44,0,3,4,III,P/CsA
